CHELSEA REAMY: Open Payments
NPI 1306100037 · GAINESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,195 in 72 payments from 20 companies in 2025. Trend: 2023 $1,171 · 2024 $2,104 · 2025 $2,195
Food & beverage: $1,695Consulting: $500
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 2 | $519 |
| LEO Pharma Inc. | 17 | $346 |
| Janssen Biotech, Inc. | 11 | $261 |
| Regeneron Healthcare Solutions, Inc. | 2 | $171 |
| Novartis Pharmaceuticals Corporation | 6 | $164 |
| ABBVIE INC. | 5 | $92 |
| Amgen Inc. | 3 | $85 |
| Galderma Laboratories, L.P. | 3 | $82 |
| UCB, Inc. | 3 | $73 |
| Incyte Corporation | 3 | $72 |
Products named: SOFDRA, ADBRY, TREMFYA, DUPIXENT, OTEZLA, NEMLUVIO, SKYRIZI, Bimzelx.
Industry payments across VA — which companies pay providers there.
